Astroglial-derived factors, as transforming growth factor (TGF)α and TGFβ, act in the hypothalamus to activate luteinizing hormone-releasing hormone (LHRH) secretion. Hypothalamic hamartomas (HHs) contain normal nervous tissue in a heterotopic location. When symptomatic, they cause precocious puberty and/or characteristic gelastic seizures. Thus far, the pathogenesis of these alterations remains unknown. By examining two HHs associated with sexual precocity, we found that they contained astroglial cells expressing TGFα, but no LHRH neurons. In a third patient with HH, only epilepsy was present, but precocious puberty developed shortly after surgery, probably as a consequence of a surgery-induced lesion. These results imply that some HHs induce sexual precocity by activating endogenous LHRH secretion via astroglial-derived factors.

Keywords:
Hamartoma, Hypothalamus, Precocious puberty, Pathogenesis
1.
Urbanski HF, Ojeda SR: A role for N-methyl-D-aspartate (NMDA) receptors in the control of LH secretion and initiation of female puberty (abstract). Endocrinology 1990;126:1774–1776.
2.
Terasawa E: Mechanisms controlling the onset of puberty in primates: the role of GABAergic neurons; in Plant TM, Lee PA (eds): The Neurobiology of Puberty. Bristol, J Endocrinol Ltd, 1995, pp 139–151.
3.
Ojeda SR, Ma Y: Transforming growth factor alpha as a physiological regulator of female puberty: neuroendocrine and molecular studies. Frontiers Endocrinol 1995;10:173–182.
4.
Ojeda SR: The neurobiology of mammalian puberty: has the contribution of glial cells been underestimated? (abstract). J NIH Res 1994;6:51–56.
5.
Mélcangi RC, Galbiati M, Messi E, Magnaghi V, Cavarreta I, Riva MA, Zanisi M: Astrocyte-neuron interactions in vitro: role of growth factors and steroids on LHRH dynamics. Brain Res Bull 1997;44:465–469.
6.
Ma YJ, Junier MP, Costa ME, Ojeda SR: Transforming growth factor-alpha gene expression in the hypothalamus is developmentally regulated and linked to sexual maturation. Neuron 1992;9:657–670.
7.
Rage F, Hill DF, Sena-Esteves M, Breakefield XO, Coffey RJ, Costa ME, McCann SM, Ojeda SR: Targeting transforming growth factor alpha expression to discrete loci of the neuroendocrine brain induces female sexual precocity. Proc Natl Acad Sci USA 1997;94:2735–2740.
8.
Lichtenstein BW: Hamartomas and phacomatoses; in Minckler J (ed): Pathology of the Nervous System. New York, McGraw-Hill, 1971, pp 1897–1906.
9.
Zuniga OF, Tanner SM, Wild WO, Mosier HD Jr: Hamartoma of CNS associated with precocious puberty. Am J Dis Child 1983;137:127–133.
10.
Berkovic SF, Kuzniecky RI, Andermann F: Human epileptogenesis and hypothalamic hamartomas: new lessons from experiment of nature. Epilepsia 1997;38:1–3.
11.
Judge DM, Kulin HE, Page R, Santen R, Trapukdi S: Hypothalamic hamartoma: a source of luteinizing-hormone-releasing factor in precocious puberty. N Engl J Med 1977;296:7–10.
12.
Kiss R, Dewitte O, Decaestecker C, Camby I, Gordower L, Delbecque K, Pasteels JL, Brotchi J, Salmon I: The combined determination of proliferative activity and cell density in the prognosis of adult patients with supratentorial high-grade astrocytic tumors. Am J Clin Pathol 1997;107:321–331.
13.
Ojeda SR, Ma YJ: Glial-neuronal interactions in the neuroendocrine control of mammalian puberty: facilitatory effects of gonadal steroids. J Neurobiol 1999;40:528–540.
14.
Ma YJ, Berg-von der Emde K, Moholt-Siebert M, Hill DF, Ojeda SR: Region-specific regulation of transforming growth factor α (TGFα) gene expression in astrocytes of the neuroendocrine brain. J Neurosci 1994;14:5644–5651.
15.
Ojeda SR, Hill J, Hill DF, Costa ME, Tapia V, Cornea A, Ma YJ: The Oct-2 POU domain gene in the neuroendocrine brain: a transcriptional regulator of mammalian puberty. Endocrinology 1999;140:3774–3789.
© 2002 S. Karger AG, Basel
2002
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.